We have French content available. View French site.

In Vivo

Show me the money

Show me the money

Drug companies pay MCO's too much in rebates and get too little in return—but "fair share" analysis can help, for some drugs, drive as much as $100 million in additional revenues.

Par Anil Shrivastava, David Bellaire and Ashish Singh

  • min

Article

Show me the money
en

Drug companies pay MCO's too much in rebates and get too little in return—but "fair share" analysis can help, for some drugs, drive as much as $100 million in additional revenues.

Download the Full Report (pdf)
Mots clés

Comment nous avons aidé nos clients

A Medical Imaging Company’s CX Overhaul Boosts Customer Satisfaction and Revenue

Lire l’étude de cas

Stratégie A healthcare payer sets its own long-term health strategy

Lire l’étude de cas

Organisation A Regional Operating Model Lifts European Sales for a Medical Device Maker

Lire l’étude de cas

Vous souhaitez continuer cette conversation ?

Nous aidons des dirigeants du monde entier à matérialiser des impacts et des résultats pérennes et créateurs de valeur dans leurs organisations.

Contacter Bain

Comment pouvons-nous vous aider ?

Voir tous les bureaux